Minerva Neurosciences NERV
NASDAQ NERV
$4.43 -0.26 (-5.54%)
At close: Sep 4, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) Intangibles (2013 - 2024)

Minerva Neurosciences' (NERV) quarterly Intangibles came in at $4257.0 in Q2 2024, down 85.71% YoY from $29797.0 in Q3 2023, and down 60.0% on a QoQ basis from $10642.0 in Q1 2024.

Analysis

Minerva Neurosciences (NERV) Intangibles (2013 - 2024) Analysis & Trends

Minerva Neurosciences (NERV) has 12 years of Intangibles data on file, last reported at $4257.0 in Q2 2024.

  • Quarterly Intangibles fell 85.71% year-over-year to $4257.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $4257.0 (down 85.71% YoY) and the FY2023 annual result came in at $17027.0, down 60.0% from the prior year.
  • Intangibles eased to $4257.0 in Q2 2024, from $10642.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $15.2 million in Q1 2020 to a low of $4257.0 in Q2 2024.
  • A 5-year average of $5.1 million and a median of $51080.0 in 2021 frame the typical range for Intangibles.
  • Annual changes were most pronounced in 2020 — Intangibles changed 0.0% — and 2021, when it sank 99.66%.
  • Tracing NERV's Intangibles over 5 years: stood at $15.2 million in 2020, then slumped by 99.66% to $51080.0 in 2021, then decreased by 16.67% to $42567.0 in 2022, then slumped by 60.0% to $17027.0 in 2023, then sank by 75.0% to $4257.0 in 2024.
  • The last three Intangibles figures came in at $4257.0 (Q2 2024), $10642.0 (Q1 2024), and $17027.0 (Q4 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 412.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 266.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 63.28 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 60.96 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 93.49 Mn
10 Minerva Neurosciences 207.37 Mn 207.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 4,257.00
Mar 31, 2024 10,642.00
Dec 31, 2023 17,027.00
Sep 30, 2023 23,412.00
Jun 30, 2023 29,797.00
Mar 31, 2023 36,182.00
Dec 31, 2022 42,567.00
Sep 30, 2022 48,952.00
Jun 30, 2022 51,080.00
Mar 31, 2022 51,080.00
Dec 31, 2021 51,080.00
Sep 30, 2021 15.20 Mn
Jun 30, 2021 15.20 Mn
Mar 31, 2021 15.20 Mn
Dec 31, 2020 15.20 Mn
Sep 30, 2020 15.20 Mn
Jun 30, 2020 15.20 Mn
Mar 31, 2020 15.20 Mn
Dec 31, 2019 15.20 Mn
Sep 30, 2019 34.20 Mn